PharmPool

Company Overview

Snapshot

Founded in April 2015, PharmPool operates with 1–10 employees. The company has secured funding across one round from one investor, 8200EISP. PharmPool helps patients manage drug therapies and reduce the risk of adverse reactions.

Business overview

PharmPool develops a mHealth mobile application designed to enhance drug therapy management and reduce adverse reactions. Its core technology utilizes a proprietary algorithm to assess drug therapy suitability based on a patient's clinical background, integrating alerts for drug interactions, drug-disease interactions, and vital signs. The application also includes features to improve drug adherence and personal drug management. PharmPool serves the health tech and life sciences sectors, providing pharmacovigilance insights and marketing analytics to pharmaceutical companies by analyzing user data on medication and disease interactions. The company operates in markets including the United States, United Kingdom, Australia, and Europe.

Company Intelligence Q&A

What is PharmPool's primary focus?

PharmPool focuses on drug therapy management and adverse reaction control through its mHealth mobile application, aiming to increase patient adherence and ensure safer drug therapies.

When was PharmPool founded?

PharmPool was founded in April 2015.

What technology does PharmPool utilize?

PharmPool utilizes a proprietary algorithm that discerns the suitability of drug therapies for specific patients, integrating alerts for drug interactions, drug-disease interactions, and vitals.

Which markets does PharmPool serve?

PharmPool serves geomarkets including the United States, United Kingdom, Australia, and Europe.

What is the primary product offered by PharmPool?

PharmPool offers a product called MedsKeeper, which is a mobile application for drug therapy management.